59
Views
167
CrossRef citations to date
0
Altmetric
Article

A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis

, , , &
Pages 3722-3737 | Received 23 Jul 2008, Accepted 27 Apr 2009, Published online: 21 Mar 2023

REFERENCES

  • Barrett, S. D., A. J. Bridges, D. T. Dudley, A. R. Saltiel, J. H. Fergus, C. M. Flamme, A. M. Delaney, M. Kaufman, S. LePage, W. R. Leopold, S. A. Przybranowski, J. Sebolt-Leopold, K. Van Becelaere, A. M. Doherty, R. M. Kennedy, D. Marston, W. A. Howard, Jr., Y. Smith, J. S. Warmus, and H. Tecle. 2008. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg. Med. Chem. Lett. 18:6501–6504.
  • Batlle, E., E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and A. Garcia De Herreros. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2:84–89.
  • Becker, K. F., E. Rosivatz, K. Blechschmidt, E. Kremmer, M. Sarbia, and H. Hofler. 2007. Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs 185:204–212.
  • Behrens, J., M. M. Mareel, F. M. Van Roy, and W. Birchmeier. 1989. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108:2435–2447.
  • Behrens, J., K. M. Weidner, U. H. Frixen, J. H. Schipper, M. Sachs, N. Arakaki, Y. Daikuhara, and W. Birchmeier. 1991. The role of E-cadherin and scatter factor in tumor invasion and cell motility. EXS 59:109–126.
  • Berx, G., E. Raspe, G. Christofori, J. P. Thiery, and J. P. Sleeman. 2007. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin. Exp. Metastasis 24:587–597.
  • Birchmeier, W., and J. Behrens. 1994. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198:11–26.
  • Blanco, M. J., G. Moreno-Bueno, D. Sarrio, A. Locascio, A. Cano, J. Palacios, and M. A. Nieto. 2002. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21:3241–3246.
  • Blay, J., and K. D. Brown. 1984. Characterization of an epithelioid cell line derived from rat small intestine: demonstration of cytokeratin filaments. Cell Biol. Int. Rep. 8:551–560.
  • Blechschmidt, K., S. Sassen, B. Schmalfeldt, T. Schuster, H. Hofler, and K. F. Becker. 2008. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br. J. Cancer 98:489–495.
  • Boudreau, N., C. J. Sympson, Z. Werb, and M. J. Bissell. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891–893.
  • Brodeur, G. M. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3:203–216.
  • Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243–247.
  • Cano, A., M. A. Perez-Moreno, I. Rodrigo, A. Locascio, M. J. Blanco, M. G. del Barrio, F. Portillo, and M. A. Nieto. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:76–83.
  • Cavallaro, U., and G. Christofori. 2001. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta 1552:39–45.
  • Christofori, G. 2006. New signals from the invasive front. Nature 441:444–450.
  • Derksen, P. W., X. Liu, F. Saridin, H. van der Gulden, J. Zevenhoven, B. Evers, J. R. van Beijnum, A. W. Griffioen, J. Vink, P. Krimpenfort, J. L. Peterse, R. D. Cardiff, A. Berns, and J. Jonkers. 2006. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10:437–449.
  • Desmet, C. J., and D. S. Peeper. 2006. The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell. Mol. Life Sci. 63:755–759.
  • Dionne, C. A., A. M. Camoratto, J. P. Jani, E. Emerson, N. Neff, J. L. Vaught, C. Murakata, D. Djakiew, J. Lamb, S. Bova, D. George, and J. T. Isaacs. 1998. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin. Cancer Res. 4:1887–1898.
  • Douma, S., T. Van Laar, J. Zevenhoven, R. Meuwissen, E. Van Garderen, and D. S. Peeper. 2004. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430:1034–1039.
  • Eccles, S. A., and D. R. Welch. 2007. Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742–1757.
  • Echeverri, C. J., P. A. Beachy, B. Baum, M. Boutros, F. Buchholz, S. K. Chanda, J. Downward, J. Ellenberg, A. G. Fraser, N. Hacohen, W. C. Hahn, A. L. Jackson, A. Kiger, P. S. Linsley, L. Lum, Y. Ma, B. Mathey-Prevot, D. E. Root, D. M. Sabatini, J. Taipale, N. Perrimon, and R. Bernards. 2006. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods 3:777–779.
  • Eide, F. F., E. R. Vining, B. L. Eide, K. Zang, X. Y. Wang, and L. F. Reichardt. 1996. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 16:3123–3129.
  • Elloul, S., M. B. Elstrand, J. M. Nesland, C. G. Trope, G. Kvalheim, I. Goldberg, R. Reich, and B. Davidson. 2005. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103:1631–1643.
  • Ernfors, P., K. F. Lee, and R. Jaenisch. 1994. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147–150.
  • Fan, Q. W., Z. A. Knight, D. D. Goldenberg, W. Yu, K. E. Mostov, D. Stokoe, K. M. Shokat, and W. A. Weiss. 2006. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9:341–349.
  • Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, and J. M. Trzaskos. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623–18632.
  • Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619–626.
  • Geiger, T. R., and D. S. Peeper. 2007. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res. 67:6221–6229.
  • Geiger, T. R., and D. S. Peeper. 2005. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Res. 65:7033–7036.
  • Gitelman, I. 1997. Twist protein in mouse embryogenesis. Dev. Biol. 189:205–214.
  • Gottardi, C. J., E. Wong, and B. M. Gumbiner. 2001. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153:1049–1060.
  • Grunert, S., M. Jechlinger, and H. Beug. 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4:657–665.
  • Gupta, G. P., and J. Massague. 2006. Cancer metastasis: building a framework. Cell 127:679–695.
  • Haapasalo, A., I. Sipola, K. Larsson, K. E. Akerman, P. Stoilov, S. Stamm, G. Wong, and E. Castren. 2002. Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms. J. Biol. Chem. 277:43160–43167.
  • Hall, P. A., P. J. Coates, B. Ansari, and D. Hopwood. 1994. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J. Cell Sci. 107:3569–3577.
  • Huang, E. J., and L. F. Reichardt. 2003. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72:609–642.
  • Huber, M. A., N. Kraut, and H. Beug. 2005. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17:548–558.
  • Ip, Y. T., R. E. Park, D. Kosman, K. Yazdanbakhsh, and M. Levine. 1992. Dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev. 6:1518–1530.
  • Janda, E., K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grunert. 2002. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299–313.
  • Jechlinger, M., S. Grunert, I. H. Tamir, E. Janda, S. Ludemann, T. Waerner, P. Seither, A. Weith, H. Beug, and N. Kraut. 2003. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22:7155–7169.
  • Jones, K. R., I. Farinas, C. Backus, and L. F. Reichardt. 1994. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76:989–999.
  • Klein, R., R. J. Smeyne, W. Wurst, L. K. Long, B. A. Auerbach, A. L. Joyner, and M. Barbacid. 1993. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75:113–122.
  • Liotta, L. A., and E. Kohn. 2004. Anoikis: cancer and the homeless cell. Nature 430:973–974.
  • Mani, S. A., W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan, A. Y. Zhou, M. Brooks, F. Reinhard, C. C. Zhang, M. Shipitsin, L. L. Campbell, K. Polyak, C. Brisken, J. Yang, and R. A. Weinberg. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715.
  • Massague, J. 2008. TGFbeta in cancer. Cell 134:215–230.
  • Masszi, A., C. Di Ciano, G. Sirokmany, W. T. Arthur, O. D. Rotstein, J. Wang, C. A. McCulloch, L. Rosivall, I. Mucsi, and A. Kapus. 2003. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am. J. Physiol. Renal Physiol. 284:F911–F924.
  • Mbalaviele, G., C. R. Dunstan, A. Sasaki, P. J. Williams, G. R. Mundy, and T. Yoneda. 1996. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res. 56:4063–4070.
  • Meredith, J. E., Jr., B. Fazeli, and M. A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4:953–961.
  • Miknyoczki, S. J., D. Lang, L. Huang, A. J. Klein-Szanto, C. A. Dionne, and B. A. Ruggeri. 1999. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int. J. Cancer 81:417–427.
  • Miyamoto, Y., J. Yamauchi, A. Tanoue, C. Wu, and W. C. Mobley. 2006. TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology. Proc. Natl. Acad. Sci. USA 103:10444–10449.
  • Moody, S. E., D. Perez, T. C. Pan, C. J. Sarkisian, C. P. Portocarrero, C. J. Sterner, K. L. Notorfrancesco, R. D. Cardiff, and L. A. Chodosh. 2005. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8:197–209.
  • Nakagawara, A., C. G. Azar, N. J. Scavarda, and G. M. Brodeur. 1994. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol. 14:759–767.
  • Nieto, M. A. 2002. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 3:155–166.
  • Noren, N. K., B. P. Liu, K. Burridge, and B. Kreft. 2000. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J. Cell Biol. 150:567–580.
  • Oft, M., J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann. 1996. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10:2462–2477.
  • Oka, H., H. Shiozaki, K. Kobayashi, M. Inoue, H. Tahara, T. Kobayashi, Y. Takatsuka, N. Matsuyoshi, S. Hirano, M. Takeichi, et al. 1993. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:1696–1701.
  • Olmeda, D., M. Jorda, H. Peinado, A. Fabra, and A. Cano. 2007. Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 26:1862–1874.
  • Olmeda, D., A. Montes, G. Moreno-Bueno, J. M. Flores, F. Portillo, and A. Cano. 2008. Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene 27:4690–4701.
  • Olmeda, D., G. Moreno-Bueno, J. M. Flores, A. Fabra, F. Portillo, and A. Cano. 2007. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res. 67:11721–11731.
  • Onder, T. T., P. B. Gupta, S. A. Mani, J. Yang, E. S. Lander, and R. A. Weinberg. 2008. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68:3645–3654.
  • Palmer, H. G., M. J. Larriba, J. M. Garcia, P. Ordonez-Moran, C. Pena, S. Peiro, I. Puig, R. Rodriguez, R. de la Fuente, A. Bernad, M. Pollan, F. Bonilla, C. Gamallo, A. G. de Herreros, and A. Munoz. 2004. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med. 10:917–919.
  • Peinado, H., D. Olmeda, and A. Cano. 2007. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7:415–428.
  • Perl, A. K., P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori. 1998. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193.
  • Price, L. S., M. Langeslag, J. P. ten Klooster, P. L. Hordijk, K. Jalink, and J. G. Collard. 2003. Calcium signaling regulates translocation and activation of Rac. J. Biol. Chem. 278:39413–39421.
  • Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401–410.
  • Rosivatz, E., K. F. Becker, E. Kremmer, C. Schott, K. Blechschmidt, H. Hofler, and M. Sarbia. 2006. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch. 448:277–287.
  • Ruggeri, B. A., S. J. Miknyoczki, J. Singh, and R. L. Hudkins. 1999. Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models. Curr. Med. Chem. 6:845–857.
  • Ruppert, J. M., B. Vogelstein, and K. W. Kinzler. 1991. The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A. Mol. Cell. Biol. 11:1724–1728.
  • Sanz-Moreno, V., G. Gadea, J. Ahn, H. Paterson, P. Marra, S. Pinner, E. Sahai, and C. J. Marshall. 2008. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510–523.
  • Sugimachi, K., S. Tanaka, T. Kameyama, K. Taguchi, S. Aishima, M. Shimada, K. Sugimachi, and M. Tsuneyoshi. 2003. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin. Cancer Res. 9:2657–2664.
  • Tapley, P., F. Lamballe, and M. Barbacid. 1992. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7:371–381.
  • Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442–454.
  • Thiery, J. P., and J. P. Sleeman. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7:131–142.
  • Vesuna, F., P. van Diest, J. H. Chen, and V. Raman. 2008. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem. Biophys. Res. Commun. 367:235–241.
  • Weinstein, I. B., and A. K. Joe. 2006. Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy. Nat. Clin. Pract. Oncol. 3:448–457.
  • Wood, E. R., L. Kuyper, K. G. Petrov, R. N. Hunter III, P. A. Harris, and K. Lackey. 2004. Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles. Bioorg. Med. Chem. Lett. 14:953–957.
  • Yang, J., S. A. Mani, J. L. Donaher, S. Ramaswamy, R. A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R. A. Weinberg. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939.
  • Yang, J., and R. A. Weinberg. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14:818–829.
  • Yang, M. H., S. Y. Chang, S. H. Chiou, C. J. Liu, C. W. Chi, P. M. Chen, S. C. Teng, and K. J. Wu. 2007. Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene 26:1459–1467.
  • Yin, T., C. Wang, T. Liu, G. Zhao, Y. Zha, and M. Yang. 2007. Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. J. Surg. Res. 141:196–203.
  • Yook, J. I., X. Y. Li, I. Ota, C. Hu, H. S. Kim, N. H. Kim, S. Y. Cha, J. K. Ryu, Y. J. Choi, J. Kim, E. R. Fearon, and S. J. Weiss. 2006. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8:1398–1406.
  • Zhou, B. P., J. Deng, W. Xia, J. Xu, Y. M. Li, M. Gunduz, and M. C. Hung. 2004. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6:931–940.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.